Generic competition, charges cut Merck Q4 profit

Merck's Q4 profit falls 7 pct on charges, generic competition to blockbuster allergy medicine

Associated Press

Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans for seeking approval of a key experimental osteoporosis drug.

The quarterly results beat Wall Street expectations, but Merck shares fell Friday as investors learned the company is reviewing safety and efficacy data from a crucial late-stage patient test of odanacatib, the osteoporosis drug.

During a morning conference call with analysts, Merck executives said that instead of applying for approval of odanacatib in the first half of this year, the company won't do so until 2014. That will allow Merck time to finish an extension of an odanacatib study that includes about 8,200 women, so that Merck can also submit those longer-term results to regulators — apparently a strategy to improve chances the drug will be approved.

"Whenever investors see a delay, and especially an unexpected delay, the instinct is to assume the worst, or at least assume a negative," which led to the stock drop, said analyst Les Funtleyder, health care strategist at private equity fund Poliwogg.

Merck shares closed down $1.42, or 3.3 percent, to $41.83.

The world's third-biggest drugmaker by revenue said net income was $1.4 billion, or 46 cents per share, down from $1.51 billion, or 49 cents per share, a year earlier.

Excluding one-time restructuring and acquisition charges totaling $1.14 billion, net income was $2.54 billion, or 83 cents per share, 2 cents more than analysts polled by research provider FactSet were expecting.

The maker of Januvia and other diabetes pills says revenue totaled $11.74 billion, down 5 percent from 2011's fourth quarter. Analysts expected $11.47 billion.

The sales drop was due to generic competition for asthma and allergy drug Singulair, which had brought Merck about $5.5 billion in annual sales until its U.S. patent expired in August, as well as for blood pressure medicines Cozaar and Hyzaar.

"Merck did have a very strong fourth quarter and a good year overall," CEO Kenneth Frazier told the analysts.

He said that despite the generic competition, the company expected to keep revenue this year at about the same level as last year's $47.27 billion.

Analysts on the conference call repeatedly asked exactly why Merck was changing its plans for odanacatib, and whether the data showed a serious risk that could block approval of the drug, which is viewed as a potential blockbuster. Company executives declined to give details.

"We continue to believe in the potential of this drug to meet the unmet needs of people with osteoporosis," Frazier said.

He noted that most women with osteoporosis aren't being treated with medication, and about a quarter of patients find they can't tolerate side effects of osteoporosis drugs in an older class called bisphosphonates. Those side effects include heartburn, nausea, diarrhea and joint pain and swelling. Merck's Fosamax, which has had generic competition for four years, was the first drug in that class and had been the top seller.

Funtleyder, the analyst, said earlier data on the drug looked very good, and he's been expecting odanacatib would eventually generate around $1 billion in annual sales.

"They seemed to have a better mousetrap," he said of the drug.

Along with the weak global economy and government health programs in many countries trying to rein in spending, Merck has been hurt by generic rivals to Singulair, which had been its top seller. In the last quarter, Singulair's global sales nosedived 67 percent to $480 million.

That pulled down total prescription drug sales by 6 percent, to $10.09 billion. Most of Merck's other big drugs produced higher sales, led by the Januvia Type 2 diabetes drug, up 18 percent to $1.13 billion, and Janumet, a diabetes combo pill, up 17 percent to $452 million.

Cholesterol-lowering drug Zetia posted a 6 percent increase in sales to $676 million, and sales jumped 61 percent to $442 million for Gardasil a vaccine against sexually transmitted cancers.

Merck's smaller divisions saw increased sales, however. Veterinary medicine sales edged up 3 percent to $898 billion. Sales of consumer health products such as Dr. Scholl's foot care products climbed 9 percent to $395 million.

Merck, based in Whitehouse Station, N.J., forecast 2013 earnings per share of $3.60 to $3.70, excluding charges. Analysts were expecting $3.68 per share.

For the full year, Merck reported net income of $6.66 billion, or $2.16 per share, up from $6.27 billion, or $2.02 per share. But sales in 2012 dipped nearly 2 percent, to $47.27 billion.

______

Linda A. Johnson can be followed at http://twitter.com/LindaJ_onPharma

View Comments

Recommended for You

  • First lady gets resume from girl with jobless dad

    WASHINGTON (AP) — Michelle Obama's annual question-and-answer session with the children of Executive Office employees took a serious turn Thursday when a 10-year-old girl in the front row told the first lady that her dad had been out of work for three years. Then the girl popped up to hand the…

    Associated Press
  • In Disney's shadow, homeless families struggle

    KISSIMMEE, Fla. (AP) — When they moved from Georgia to the theme park playground of central Florida four years ago, Anthony and Candice Johnson found work at a barbecue restaurant and a 7-Eleven. Their combined salaries nevertheless fell short of what they needed to rent an apartment, so the couple…

    Associated Press
  • The New Sedan that Stands Out from the Crowd

    Incredible driving with incredible fuel efficiency is now a reality. New 2014 Models have just arrived! Search online for dealer inventory.

    AdChoices Mazda USASponsored
  • Musk’s Tesla Income Plummets 99.9% to Less Than $70,000

    Elon Musk, Tesla Motors Inc. (TSLA) ’s chief executive and one of the wealthiest U.S. entrepreneurs, saw his take-home pay from the automaker plunge by more than 99.9 percent last year after a surge in his 2012 stock options. Compensation for the leader of the youngest publicly held U.S. automaker…

    Bloomberg
  • Play

    Best Credit Card for Travel Rewards?

    WSJ travel columnist Scott McCartney discusses the new Orbitz reward credit card and others that up the ante for the travel rewards category on Lunch Break.

    WSJ Live
  • Putin Says Visa and MasterCard Will Lose Market Share

    Russian President Vladimir Putin said Visa Inc. (V) and MasterCard Inc. (MA) will lose market share in Russia after they blocked some transactions because of U.S. sanctions on individuals and banks. “We don’t see any steps to punish unconscionable partners, but they are undermining trust, hence…

    Bloomberg
  • Cramer: Tech stock heading to $70

    Jim Cramer looks at many metrics as he decides where to put money. And in the case of this tech firm, he's spotted something very bullish.

    CNBC
  • Why it may be time to fold on casinos

    Casino stocks have been on a winning streak. But is it time to fold them?

    Talking Numbers
  • Here's why the biotech bounce may be short lived

    Will biotech get its mojo back or is it a dead cat bounce?

    Talking Numbers
  • Is your home ready?

    The best of soccer is coming! Get FiOS and bring the stadium home. Discover how.

    AdChoices Verizon FiOSSponsored
  • Russia's Putin calls the Internet a 'CIA project'

    MOSCOW (AP) — President Vladimir Putin on Thursday called the Internet a CIA project and made comments about Russia's biggest search engine Yandex, sending the company's shares plummeting.

    Associated Press
  • Postal workers' unions protest Staples program

    CONCORD, N.H. (AP) — Postal workers in cities big and small protested in front of Staples stores on Thursday, objecting to the U.S. Postal Service's pilot program to open counters in stores, staffed with retail employees.

    Associated Press
  • North Dakota finds more radioactive oil waste

    BISMARCK, N.D. (AP) — North Dakota confirmed Thursday the discovery of a new radioactive dump of waste from oil drilling, and separately a company hired to clean up waste found in February at another location said it removed double the amount of radioactive material originally estimated to be there.

    Associated Press
  • Business Insider
  • Buffett disapproves of Coca-Cola's pay plan

    NEW YORK (AP) — Warren Buffett criticized Coca-Cola's pay plan for its executives on Wednesday.

    Associated Press
  • Pros and Cons of Paying Off Your Student Loans Early

    While paying off your student loans early seems like a no-brainer, it might not always be the best financial decision. Here are some of the pros and cons to paying off your student loans early, and some tips on how to pay them off. Paying off your student loan debt early can save you a good chunk…

    The Fiscal Times
  • Google Chromecast for $35

    Enjoy online video & anything from the web on your TV. Buy yours now!

    AdChoices GoogleSponsored
  • US oil stockpiles hit record amid production boom

    US commercial oil stockpiles hit a new record last week on the strength of continued growth in oil and gas production in the world's biggest oil-consuming country. Commercial stocks rose 3.5 million barrels to 397.7 million barrels for the week ended April 18, according to US Energy Information…

    AFP
  • United loses $609M in 1Q; fares don't cover costs

    United Airlines is the one U.S. carrier that can't seem to get its act together.

    Associated Press
  • Study: US manufacturers gaining competitiveness

    WASHINGTON (AP) — U.S. manufacturers have grown more competitive over the past decade compared with factories in China, Brazil and most of the world's other major economies.

    Associated Press
  • Play

    Wall Street Bracing for Key Tech Earnings

    Polya Lesova takes a look at the markets, including three stocks to watch today. Photo: Andrew St. Clair for The Wall Street Journal.

    WSJ Live
  • Amazon launches grocery service for Prime members

    NEW YORK (AP) — Amazon is taking aim at grocery stores and discounters like Wal-Mart with a grocery service that lets its Prime loyalty club members fill up to a 45-pound box with groceries and get it shipped for a flat rate of $5.99.

    Associated Press
  • Play

    Microsoft Posts Smaller-Than-Expected Profit Decline

    The first earnings report for Microsoft under new CEO Satya Nadella showed strong fiscal third-quarter sales from office tools, database and others programs for computer centers. WSJ's Shira Ovide and Scott Thurm report. (Photo: AP)

    WSJ Live
  • 10 Best Midsized SUVs for 2014

    Midsized SUVs come in many shapes and sizes. There's 2-row and 3-row seating, 4-wheel drive and more! We've found this year's best options for you!

    AdChoices Kelley Blue BookSponsored